相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blood-Brain Barrier Disruption Is Initiated During Primary HIV Infection and Not Rapidly Altered by Antiretroviral Therapy
Elham Rahimy et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Cerebrospinal fluid cell-free mitochondrial DNA is associated with HIV replication, iron transport, and mild HIV-associated neurocognitive impairment
Sanjay R. Mehta et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype
Shorena Janelidze et al.
NEUROBIOLOGY OF AGING (2017)
Human Immunodeficiency Virus Promotes Mitochondrial Toxicity
Summer J. Rozzi et al.
NEUROTOXICITY RESEARCH (2017)
Genome-Wide Association Study of HIV-Associated Neurocognitive Disorder (HAND): A CHARTER Group Study
Peilin Jia et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2017)
Cerebrospinal fluid (CSF) biomarkers of iron status are associated with CSF viral load, antiretroviral therapy, and demographic factors in HIV-infected adults
Stephanie M. Patton et al.
FLUIDS AND BARRIERS OF THE CNS (2017)
Anemia and Red Blood Cell Indices Predict HIV-Associated Neurocognitive Impairment in the Highly Active Antiretroviral Therapy Era
Asha R. Kallianpur et al.
JOURNAL OF INFECTIOUS DISEASES (2016)
Neurologic Complications in Treated HIV-1 Infection
Nisha S. Bhatia et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2016)
HIV-associated neurocognitive disorder - pathogenesis and prospects for treatment (vol 12, pg 234, 2016)
Deanna Saylor et al.
NATURE REVIEWS NEUROLOGY (2016)
Vascular endothelial growth factor: a neurovascular target in neurological diseases
Christian Lange et al.
NATURE REVIEWS NEUROLOGY (2016)
Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment
Arvid Eden et al.
PLOS ONE (2016)
Mitochondrial DNA Haplogroups and Neurocognitive Impairment During HIV Infection
Todd Hulgan et al.
CLINICAL INFECTIOUS DISEASES (2015)
Functional role of inorganic trace elements in angiogenesis-Part I: N, Fe, Se, P, Au, and Ca
Mohammad Ali Saghiri et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2015)
Mechanisms of HIV-1 Tat Neurotoxicity via CDK5 Translocation and Hyper-Activation: Role in HIV-Associated Neurocognitive Disorders
Jerel Adam Fields et al.
CURRENT HIV RESEARCH (2015)
Hephaestin and Ceruloplasmin Play Distinct but Interrelated Roles in Iron Homeostasis in Mouse Brain
Ruiwei Jiang et al.
JOURNAL OF NUTRITION (2015)
Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy
Ryan C. McCarthy et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2015)
Developmental and pathological angiogenesis in the central nervous system
Mario Vallon et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Ceruloplasmin and β-amyloid precursor protein confer neuroprotection in traumatic brain injury and lower neuronal iron
Scott Ayton et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders
Alexander J. Gill et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
HIV infection of macrophages is enhanced in the presence of increased expression of CD163 induced by substance P
Florin Tuluc et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2014)
Controversies in HIV-associated neurocognitive disorders
Sam Nightingale et al.
LANCET NEUROLOGY (2014)
Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline
Igor Grant et al.
NEUROLOGY (2014)
Host Genetic Factors Predisposing to HIV-Associated Neurocognitive Disorder
A. R. Kallianpur et al.
CURRENT HIV/AIDS REPORTS (2014)
Elevated sCD163 in plasma but not cerebrospinal fluid is a marker of neurocognitive impairment in HIV infection
Tricia H. Burdo et al.
AIDS (2013)
Assessment, Diagnosis, and Treatment of HIV-Associated Neurocognitive Disorder: A Consensus Report of the Mind Exchange Program
Andrea Antinori et al.
CLINICAL INFECTIOUS DISEASES (2013)
Monocyte/macrophages and their role in HIV neuropathogenesis
Tricia H. Burdo et al.
IMMUNOLOGICAL REVIEWS (2013)
Targeting the Glutamatergic System for the Treatment of HIV-Associated Neurocognitive Disorders
Michelle C. Potter et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Expression of substance P, neuroldnin-1 receptor and immune markers in the brains of individuals with HIV-associated neuropathology
Sergei Spitsin et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
The Haptoglobin-CD163-Heme Oxygenase-1 Pathway for Hemoglobin Scavenging
Jens Haugbolle Thomsen et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Micro-Structural Brain Alterations in Aviremic HIV plus Patients with Minor Neurocognitive Disorders: A Multi-Contrast Study at High Field
Cristina Granziera et al.
PLOS ONE (2013)
Cuprizone-induced demyelination in mice: age-related vulnerability and exploratory behavior deficit
Hongkai Wang et al.
NEUROSCIENCE BULLETIN (2013)
Immune cells and hepatocytes express glycosylphosphatidylinositol-anchored ceruloplasmin at their cell surface
Liliana Marques et al.
BLOOD CELLS MOLECULES AND DISEASES (2012)
Ceruloplasmin alters intracellular iron regulated proteins and pathways: Ferritin, transferrin receptor, glutamate and hypoxia-inducible factor-1α
J. Harned et al.
EXPERIMENTAL EYE RESEARCH (2012)
Neurological diseases in relation to the blood-brain barrier
Gary A. Rosenberg
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
Ceruloplasmin deficiency results in an anxiety phenotype involving deficits in hippocampal iron, serotonin, and BDNF
Sarah J. Texel et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Association of haptoglobin phenotypes with ceruloplasmin ferroxidase activity in β-thalassemia major
Samir M. Awadallah et al.
CLINICA CHIMICA ACTA (2011)
Differential Expression of CD163 on Monocyte Subsets in Healthy and HIV-1 Infected Individuals
Emma Tippett et al.
PLOS ONE (2011)
Iron and Immunity: Immunological Consequences of Iron Deficiency and Overload
Bobby J. Cherayil
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2010)
HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy CHARTER Study
R. K. Heaton et al.
NEUROLOGY (2010)
Neuroprotective Role of Haptoglobin after Intracerebral Hemorrhage
Xiurong Zhao et al.
JOURNAL OF NEUROSCIENCE (2009)
CD163, a marker of perivascular macrophages, is up-regulated by microglia in simian immunodeficiency virus encephalitis after haptoglobin-hemoglobin complex stimulation and is suggestive of breakdown of the blood-brain barrier
Juan T. Borda et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Polymorphism of human haptoglobin and its clinical importance
Vania Peretti de Albuquerque Wobeto et al.
GENETICS AND MOLECULAR BIOLOGY (2008)
Sera proteomic biomarker profiling in HIV-1 infected subjects with cognitive impairment
Wbiciech Rozek et al.
PROTEOMICS CLINICAL APPLICATIONS (2008)
Features of ceruloplasmin in the cerebrospinal fluid of Alzheimer's disease patients
Concetta R. Capo et al.
BIOMETALS (2008)
Updated research nosology for HIV-associated neurocognitive disorders
A. Antinori et al.
NEUROLOGY (2007)
Activation of microglial cells by ceruloplasmin
Kyung-Hee Lee et al.
BRAIN RESEARCH (2007)
Vascular endothelial growth factor (VEGF) is increased in serum, but not in cerebrospinal fluid in HIV associated CNS diseases
B Sporer et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2004)
CD163: a regulated hemoglobin scavenger receptor with a role in the anti-inflammatory response
SK Moestrup et al.
ANNALS OF MEDICINE (2004)
分享论文
